Frazier Life Sciences Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.37M | Hold |
3,868,750
| – | – | 0.17% | 45 |
|
|
2025
Q1 | $5.65M | Buy |
3,868,750
+1,001,000
| +35% | +$1.46M | 0.26% | 39 |
|
|
2024
Q4 | $6.11M | Hold |
2,867,750
| – | – | 0.25% | 45 |
|
|
2024
Q3 | $8.03M | Hold |
2,867,750
| – | – | 0.32% | 41 |
|
|
2024
Q2 | $6.68M | Hold |
2,867,750
| – | – | 0.31% | 43 |
|
|
2024
Q1 | $12.8M | Buy |
+2,867,750
| New | +$12.8M | 0.54% | 39 |
|